Maryam Azhir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maryam Azhir has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Behnaz Bazrafshan
School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran
1 shared publication - Leila Elyasi
Neuroscience Research Center, Department of Anatomy, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
1 shared publication - Mehrdad Jahanshahi
Neuroscience Research Center, Golestan University of Medical Sciences, Gorgan, Iran
1 shared publication - Sara Gazmeh
Neuroscience Research Center, Golestan University of Medical Sciences, Gorgan, Iran
1 shared publication
Latest Publications
- Open Access
- 1 January 2023
- Published by Apex Publishing in Journal of Clinical and Basic Research
- Vol. 7 (4) , 15-19
The effect of apelin-13 on memory of scopolamine-treated rats and accumulation of amyloid-beta plaques in the hippocampus
Background: Neurodegenerative diseases (NDDs) cause progressive neuronal loss, resulting in morbidity and mortality. Research is continued on treatment strategies that can tackle the disease's pathophysiology and cease its progression. Considering the anti-apoptotic and neuroprotective properties of apelin, we hypothesized that apelin-13 could be a therapeutic solution for Alzheimer's disease and similar ...
- 1 January 2023
- Published by Apex Publishing in Journal of Clinical and Basic Research
- Vol. 7 (4) , 15-19
Open AccessThe effect of apelin-13 on memory of scopolamine-treated rats and accumulation of amyloid-beta plaques in the hippocampus
Background: Neurodegenerative diseases (NDDs) cause progressive neuronal loss, resulting in morbidity and mortality. Research is continued on treatment strategies that can tackle the disease's pathophysiology and cease its progression. Considering the anti-apoptotic and neuroprotective properties of apelin, we hypothesized that apelin-13 could be a therapeutic solution for Alzheimer's disease and similar ...